Classification
- Anatomical main groupNNervous system
- Therapeutic subgroupN04
- Pharmacological subgroupN04B
- Chemical subgroupN04BC
- Chemical substanceN04BC05Pramipexole
Where it is registered
Each register with its number of medicines and a few of them.
Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
AEMPS · 58 medicines
Anvisa · 37 medicines
MS · 19 medicines · Historical list
AIFA · 16 medicines
ALIMS · 10 medicines
HALMED · 9 medicines
EMA · 6 medicines
SFDA · 4 medicines · Historical list
FDA · 4 medicines
HSA · 3 medicines
TFDA · 3 medicines
PHARMAC · 2 medicines
Every register, a page at a time. Strengths and packs are on each medicine’s page.
58 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| PRAMIPEXOL TEVA 0,7 mg COMPRIMIDOS EFG | Spain | 0,7 mg | comprimido | Marketed | Teva B.V. |
| PRAMIPEXOL PENSA 0,18 mg COMPRIMIDOS EFG | Spain | 0,180 mg | comprimido | Marketed | Towa Pharmaceutical S.A. |
| PRAMIPEXOL STADA 0.7 mg COMPRIMIDOS EFG | Spain | 0,700 mg | comprimido | Marketed | Laboratorio Stada S.L. |
| PRAMIPEXOL TEVA 0,18 mg COMPRIMIDOS EFG | Spain | 0,18 mg | comprimido | Marketed | Teva B.V. |
| PRAMIPEXOL NORMON 0,7 mg COMPRIMIDOS EFG | Spain | 0,7 mg | comprimido | Marketed | Laboratorios Normon S.A. |
| PRAMIPEXOL STADA 0.18 mg COMPRIMIDOS EFG | Spain | 0,18 mg | comprimido | Marketed | Laboratorio Stada S.L. |
| PRAMIPEXOL NORMON 0,18 mg COMPRIMIDOS EFG | Spain | 0,18 mg | comprimido | Marketed | Laboratorios Normon S.A. |
| PRAMIPEXOL KERN PHARMA 0,7 mg COMPRIMIDOS EFG | Spain | 0,7 mg | comprimido | Marketed | Kern Pharma S.L. |
| PRAMIPEXOL KERN PHARMA 0,18 mg COMPRIMIDOS EFG | Spain | 0,18 mg | comprimido | Marketed | Kern Pharma S.L. |
| PRAMIPEXOL PENSA 0,7 mg COMPRIMIDOS EFG | Spain | 0,70 mg | comprimido | Authorised | Towa Pharmaceutical S.A. |
| PRAMIPEXOL TEVA 0,7 mg COMPRIMIDOS EFG | Spain | 0,7 mg | comprimido | Authorised | Teva B.V. |
| PRAMIPEXOL TEVA 0,088 mg COMPRIMIDOS EFG | Spain | 0,088 mg | comprimido | Authorised | Teva B.V. |
| PRAMIPEXOL TEVA 0,18 mg COMPRIMIDOS EFG | Spain | 0,18 mg | comprimido | Authorised | Teva B.V. |
| Pramipexol Ratiopharm 2,1 MG Comprimidos de Liberacion Prolongada Efg | Spain | 2,1 mg | comprimido de liberación prolongada | Marketed | Teva Pharma S.L.U. |
| Pramipexol Ratiopharm 1,05 MG Comprimidos de Liberacion Prolongada Efg | Spain | 1,05 mg | comprimido de liberación prolongada | Marketed | Teva Pharma S.L.U. |
| Pramipexol Sandoz Farmaceutica 2,1 MG Comprimidos de Liberacion Prolongada Efg | Spain | 2,1 mg | comprimido de liberación prolongada | Marketed | Sandoz Farmaceutica S.A. |
| Pramipexol Sandoz Farmaceutica 0,26 MG Comprimidos de Liberacion Prolongada Efg | Spain | 0,26 mg | comprimido de liberación prolongada | Marketed | Sandoz Farmaceutica S.A. |
| Pramipexol Sandoz Farmaceutica 1,05 MG Comprimidos de Liberacion Prolongada Efg | Spain | 1,05 mg | comprimido de liberación prolongada | Marketed | Sandoz Farmaceutica S.A. |
| Mirapexin 2,1 MG Comprimidos de Liberacion Prolongada | Spain | 2,1 mg | comprimido de liberación prolongada | Marketed | Boehringer Ingelheim International Gmbh |
| Mirapexin 2,1 MG Comprimidos de Liberacion Prolongada | Spain | 2,1 mg | comprimido de liberación prolongada | Marketed | Boehringer Ingelheim International Gmbh |
| MIRAPEXIN 2,1 mg COMPRIMIDOS DE LIBERACION PROLONGADA | Spain | 2,1 mg | comprimido de liberación prolongada | Marketed | Boehringer Ingelheim International Gmbh |
| Mirapexin 2,1 MG Comprimidos de Liberacion Prolongada | Spain | 2,1 mg | comprimido de liberación prolongada | Marketed | Boehringer Ingelheim International Gmbh |
| Mirapexin 2,1 MG Comprimidos de Liberacion Prolongada | Spain | 2,1 mg | comprimido de liberación prolongada | Marketed | Boehringer Ingelheim International Gmbh |
| MIRAPEXIN 0,26 mg COMPRIMIDOS DE LIBERACION PROLONGADA | Spain | 0,26 mg | comprimido de liberación prolongada | Marketed | Boehringer Ingelheim International Gmbh |
| Mirapexin 1,05 MG Comprimidos de Liberacion Prolongada | Spain | 1,05 mg | comprimido de liberación prolongada | Marketed | Boehringer Ingelheim International Gmbh |
The same brand on several registers.
The companies holding its medicines, the most first.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, ALIMS, Anvisa, CBG-MEB, EMA, FDA, HALMED, Health Canada, HSA, MS, PHARMAC, SFDA and TFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.